A prospective randomized controlled study of erythromycin on gastric and small intestinal distention: Implications for MR enterography

•Suboptimal small intestinal distention limits jejunal visualization during MRI.•In this controlled study, erythromycin increased gastric emptying measured with MRI.•However, effects on small intestinal dimensions were variable. To assess if erythromycin increases gastric emptying and hence improves...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of radiology Vol. 83; no. 11; pp. 2001 - 2006
Main Authors Bharucha, Adil E., Fidler, Jeff L., Huprich, James E., Ratuapli, Shiva K., Holmes, David R., Riederer, Stephen J., Zinsmeister, Alan R.
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.11.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Suboptimal small intestinal distention limits jejunal visualization during MRI.•In this controlled study, erythromycin increased gastric emptying measured with MRI.•However, effects on small intestinal dimensions were variable. To assess if erythromycin increases gastric emptying and hence improves small intestinal distention during MR enterography. Gastric, small intestinal, and large intestinal volumes were assessed with MR after neutral oral contrast (1350ml in 45min) and balanced randomization to erythromycin (200mg i.v., age 31±3y, 13 females), or placebo (37±3y, 13 females) in 40 healthy asymptomatic volunteers. Fat-suppressed T2-weighted MR images of the abdomen were acquired on a 1.5T magnet at standard delay times for enterography. Gastric, small, and large intestinal volumes were measured by specialized software. In addition, two radiologists manually measured diameters and percentage distention of jejunal and ileal loops. Treatment effects were evaluated by an ITT analysis based on ANCOVA models. All subjects tolerated erythromycin. MRI scans of the stomach and intestine were obtained at 62±2 (mean±SEM) and 74±2min respectively after starting oral contrast. Gastric volumes were lower (P<0.0001) after erythromycin (260±49ml) than placebo (688±63ml) but jejunal, ileal, and colonic volumes were not significantly different. However, maximum (76–100%) jejunal distention was more frequently observed (P=0.03) after erythromycin (8/20 subjects [40%]) than placebo (2/20 subjects [10%]). The diameter of a representative ileal loop was greater (P=0.001) after erythromycin (18.8±4.3mm) than placebo (17.3±2.8mm) infusion. After ingestion of oral contrast, erythromycin accelerated gastric emptying but effects on small intestinal dimensions were variable. In balance, erythromycin did not substantially enhance small intestinal distention during enterography using current standard delay times.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Dr. Ratuapli’s present address is Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.
James E. Huprich, (huprich@mayo.edu, (507 284 2691)
Alan R. Zinsmeister, (zinsmeis@mayo.edu, (507) 284 4156)
Adil E. Bharucha, (bharucha.adil@mayo.edu, (507) 284 2687)
David R. Holmes, (holmes.david3@mayo.edu, (507) 266 4250)
Jeff L. Fidler, (fidler.jeff@mayo.edu, (507) 284 3207)
Shiva K. Ratuapli, (ratuapli.shiva@mayo.edu, (480) 301 6990)
Stephen J. Riederer, (riederer@mayo.edu, (507) 284 9780)
ISSN:0720-048X
1872-7727
1872-7727
DOI:10.1016/j.ejrad.2014.08.005